Trials / Enrolling By Invitation
Enrolling By InvitationNCT06604130
Plasma Exosome RNA to Diagnose Prostate Cancer
Plasma Exosome RNA Combination for Diagnosing Prostate Cancer: a Prospective, Multicenter Diagnostic Trial
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,600 (estimated)
- Sponsor
- Xijing Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to investigate a RNA combination to diagnose prostate cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Prostate cancer screening decision | The subjects would receive serum PSA test. |
Timeline
- Start date
- 2021-03-12
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
- First posted
- 2024-09-19
- Last updated
- 2025-11-28
Locations
9 sites across 1 country: China
Source: ClinicalTrials.gov record NCT06604130. Inclusion in this directory is not an endorsement.